|
Entity | Shares/Amount Change | Position Value Change |
CCCC |
+4,878,000 | +$27,561 | GPCR |
+486,832 | +$19,843 | ARVN |
+421,348 | +$17,343 | HARP |
+1,500,000 | +$17,055 | SABS |
+2,374,081 | +$1,632 |
Entity | Shares/Amount Change | Position Value Change |
COGT |
-6,416,147 | -$62,557 | SLNO |
-1,239,000 | -$36,563 | VRDN |
-2,007,946 | -$30,802 | ACRS |
-4,398,453 | -$30,129 | EYPT |
-3,370,506 | -$26,930 | CELC |
-1,400,001 | -$12,796 | NKTR |
-18,700,000 | -$11,138 | TALS |
-2,403,238 | -$6,753 | NSTG |
-1,723,373 | -$2,964 |
Entity | Shares/Amount Change | Position Value Change |
IMGN |
+10,428,313 | +$492,780 | MGNX |
+3,711,077 | +$37,397 | CMRX |
+2,298,376 | +$2,230 | URGN |
+1,599,733 | +$25,464 | THRD |
+1,071,193 | +$16,157 | WVE |
+1,000,000 | -$6,992 | RXST |
+351,489 | +$52,119 | ALPN |
+218,585 | +$39,866 | PCVX |
UNCH | +$93,275 | LEGN |
UNCH | -$43,853 |
Entity | Shares/Amount Change | Position Value Change |
CVAC |
-7,860,074 | -$60,875 | RNA |
-3,962,465 | -$18,726 | CNTB |
-3,928,132 | -$2,112 | TNYA |
-1,211,136 | +$712 | NAMS |
-1,136,000 | +$4,591 | ASND |
-612,155 | +$269,248 | PLRX |
-481,000 | -$7,354 | RYTM |
-345,655 | +$114,915 | EVH |
-187,548 | +$9,678 |
Size ($ in 1000's)
At 12/31/2023: $6,402,500 At 09/30/2023: $5,079,718
RA Capital Management L.P. holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from RA Capital Management L.P. 13F filings.
Link to 13F filings: SEC filings
|
|
|
As of 12/31/2023, we find all stocks held by RA Capital Management L.P. to be as follows, presented in the
table below with each row detailing each RA Capital Management L.P. position, ordered by largest to smallest position size.
The all-stocks-held-by-RA Capital Management L.P. table shows the entity held in the first column (click any entity to explore other funds
holding positions), the share amount held, the share count change between the last two reporting periods, and finally the
position size for all stocks held by RA Capital Management L.P. as of the latest filing.
Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size
($ in 1000's) |
ASCENDIS PHARMA A S ADR |
10,107,400 |
-612,155 |
$1,273,027 | ASND | 10,107,400 | -612,155 | $1,273,027 | IMMUNOGEN INC |
23,750,601 |
+10,428,313 |
$704,205 | IMGN | 23,750,601 | +10,428,313 | $704,205 | VAXCYTE INC |
7,891,254 |
UNCH |
$495,571 | PCVX | 7,891,254 | UNCH | $495,571 | LEGEND BIOTECH CORP ADR |
6,264,707 |
UNCH |
$376,947 | LEGN | 6,264,707 | UNCH | $376,947 | RHYTHM PHARMACEUTICALS INC |
5,330,412 |
-345,655 |
$245,039 | RYTM | 5,330,412 | -345,655 | $245,039 | AEROVATE THERAPEUTICS INC |
8,263,982 |
UNCH |
$187,014 | AVTE | 8,263,982 | UNCH | $187,014 | INHIBRX INC |
4,724,207 |
UNCH |
$179,520 | INBX | 4,724,207 | UNCH | $179,520 | CYMABAY THERAPEUTICS INC |
6,940,000 |
UNCH |
$163,923 | CBAY | 6,940,000 | UNCH | $163,923 | BIOGEN INC |
532,892 |
UNCH |
$137,896 | BIIB | 532,892 | UNCH | $137,896 | RXSIGHT INC |
3,404,285 |
+351,489 |
$137,261 | RXST | 3,404,285 | +351,489 | $137,261 | 89BIO INC |
11,416,948 |
UNCH |
$127,527 | ETNB | 11,416,948 | UNCH | $127,527 | VERONA PHARMA PLC ADR |
6,317,990 |
UNCH |
$125,602 | VRNA | 6,317,990 | UNCH | $125,602 | DAY ONE BIOPHARMACEUTICALS I |
7,809,852 |
UNCH |
$114,024 | DAWN | 7,809,852 | UNCH | $114,024 | AN2 THERAPEUTICS INC |
5,551,295 |
UNCH |
$113,746 | ANTX | 5,551,295 | UNCH | $113,746 | TYRA BIOSCIENCES INC |
7,236,454 |
UNCH |
$100,225 | TYRA | 7,236,454 | UNCH | $100,225 | JANUX THERAPEUTICS INC |
9,165,652 |
UNCH |
$98,347 | JANX | 9,165,652 | UNCH | $98,347 | GERON CORP |
46,202,425 |
UNCH |
$97,487 | GERN | 46,202,425 | UNCH | $97,487 | ICOSAVAX INC |
5,963,565 |
UNCH |
$93,986 | ICVX | 5,963,565 | UNCH | $93,986 | ALPINE IMMUNE SCIENCES INC |
4,909,763 |
+218,585 |
$93,580 | ALPN | 4,909,763 | +218,585 | $93,580 | WAVE LIFE SCIENCES LTD |
18,202,009 |
+1,000,000 |
$91,920 | WVE | 18,202,009 | +1,000,000 | $91,920 | NEWAMSTERDAM PHARMA CO NV |
7,864,000 |
-1,136,000 |
$87,841 | NAMS | 7,864,000 | -1,136,000 | $87,841 | 4D MOLECULAR THERAPEUTICS IN |
4,163,211 |
UNCH |
$84,347 | FDMT | 4,163,211 | UNCH | $84,347 | EVOLENT HEALTH INC A |
2,549,132 |
-187,548 |
$84,198 | EVH | 2,549,132 | -187,548 | $84,198 | AXSOME THERAPEUTICS INC |
1,000,000 |
UNCH |
$79,590 | AXSM | 1,000,000 | UNCH | $79,590 | FULCRUM THERAPEUTICS INC |
11,609,704 |
UNCH |
$78,366 | FULC | 11,609,704 | UNCH | $78,366 | CYTEK BIOSCIENCES INC |
6,809,404 |
UNCH |
$62,102 | CTKB | 6,809,404 | UNCH | $62,102 | ACUMEN PHARMACEUTICALS INC |
14,932,063 |
UNCH |
$57,339 | ABOS | 14,932,063 | UNCH | $57,339 | PEPGEN INC |
8,131,952 |
UNCH |
$55,297 | PEPG | 8,131,952 | UNCH | $55,297 | APOGEE THERAPEUTICS INC |
1,977,901 |
UNCH |
$55,263 | APGE | 1,977,901 | UNCH | $55,263 | ARS PHARMACEUTICALS INC |
9,459,678 |
UNCH |
$51,839 | SPRY | 9,459,678 | UNCH | $51,839 | NKARTA INC |
7,805,129 |
UNCH |
$51,514 | NKTX | 7,805,129 | UNCH | $51,514 | VOR BIOPHARMA INC |
22,748,880 |
UNCH |
$51,185 | VOR | 22,748,880 | UNCH | $51,185 | ITEOS THERAPEUTICS INC |
4,417,259 |
UNCH |
$48,369 | ITOS | 4,417,259 | UNCH | $48,369 | MADRIGAL PHARMACEUTICALS INC |
204,500 |
UNCH |
$47,317 | MDGL | 204,500 | UNCH | $47,317 | UROGEN PHARMA LTD |
3,083,430 |
+1,599,733 |
$46,251 | URGN | 3,083,430 | +1,599,733 | $46,251 | MACROGENICS INC |
4,053,077 |
+3,711,077 |
$38,991 | MGNX | 4,053,077 | +3,711,077 | $38,991 | ELIEM THERAPEUTICS INC |
13,150,849 |
UNCH |
$35,507 | ELYM | 13,150,849 | UNCH | $35,507 | TAYSHA GENE THERAPIES INC |
18,472,503 |
UNCH |
$32,696 | TSHA | 18,472,503 | UNCH | $32,696 | GH RESEARCH PLC |
5,587,333 |
UNCH |
$32,407 | GHRS | 5,587,333 | UNCH | $32,407 | ENLIVEN THERAPEUTICS INC |
2,122,465 |
UNCH |
$29,375 | ELVN | 2,122,465 | UNCH | $29,375 | C4 THERAPEUTICS INC |
4,878,000 |
+4,878,000 |
$27,561 | CCCC | 4,878,000 | +4,878,000 | $27,561 | MINERALYS THERAPEUTICS INC |
3,178,476 |
UNCH |
$27,335 | MLYS | 3,178,476 | UNCH | $27,335 | WEREWOLF THERAPEUTICS INC |
6,144,881 |
UNCH |
$23,719 | HOWL | 6,144,881 | UNCH | $23,719 | ACRIVON THERAPEUTICS INC |
4,810,508 |
UNCH |
$23,668 | ACRV | 4,810,508 | UNCH | $23,668 | PLIANT THERAPEUTICS INC |
1,281,000 |
-481,000 |
$23,199 | PLRX | 1,281,000 | -481,000 | $23,199 | THIRD HARMONIC BIO INC |
2,033,056 |
+1,071,193 |
$22,303 | THRD | 2,033,056 | +1,071,193 | $22,303 | AVIDITY BIOSCIENCES INC |
2,454,533 |
-3,962,465 |
$22,214 | RNA | 2,454,533 | -3,962,465 | $22,214 | SOLID BIOSCIENCES INC |
3,426,286 |
UNCH |
$21,037 | SLDB | 3,426,286 | UNCH | $21,037 | STRUCTURE THERAPEUTICS INC |
486,832 |
+486,832 |
$19,843 | GPCR | 486,832 | +486,832 | $19,843 | TENAYA THERAPEUTICS INC |
5,507,347 |
-1,211,136 |
$17,844 | TNYA | 5,507,347 | -1,211,136 | $17,844 | ARVINAS INC |
421,348 |
+421,348 |
$17,343 | ARVN | 421,348 | +421,348 | $17,343 | HARPOON THERAPEUTICS INC |
1,500,000 |
+1,500,000 |
$17,055 | HARP | 1,500,000 | +1,500,000 | $17,055 | BICYCLE THERAPEUTICS PLC ADR |
800,000 |
UNCH |
$14,464 | BCYC | 800,000 | UNCH | $14,464 | CUREVAC NV |
2,744,270 |
-7,860,074 |
$11,553 | CVAC | 2,744,270 | -7,860,074 | $11,553 | COMPASS PATHWAYS PLC |
1,286,000 |
UNCH |
$11,252 | CMPS | 1,286,000 | UNCH | $11,252 | BLACK DIAMOND THERAPEUTICS I |
3,525,754 |
UNCH |
$9,907 | BDTX | 3,525,754 | UNCH | $9,907 | CHIMERIX INC |
8,800,000 |
+2,298,376 |
$8,470 | CMRX | 8,800,000 | +2,298,376 | $8,470 | IGM BIOSCIENCES INC |
937,500 |
UNCH |
$7,791 | IGMS | 937,500 | UNCH | $7,791 | CONNECT BIOPHARMA HOLDINGS L |
3,062,871 |
-3,928,132 |
$3,614 | CNTB | 3,062,871 | -3,928,132 | $3,614 | UNICYCIVE THERAPEUTICS INC |
3,470,688 |
UNCH |
$3,012 | UNCY | 3,470,688 | UNCH | $3,012 | SAB BIOTHERAPEUTICS INC |
2,374,081 |
+2,374,081 |
$1,632 | SABS | 2,374,081 | +2,374,081 | $1,632 | NEWAMSTERDAM PHARMA CO NV 27 |
333,333 |
+0 |
$1,043 | NAMSW | 333,333 | UNCH | $1,043 | ACLARIS THERAPEUTICS INC |
|
|
$0 (exited) | ACRS | 0 | -4,398,453 | $0 | CELCUITY INC |
|
|
$0 (exited) | CELC | 0 | -1,400,001 | $0 | COGENT BIOSCIENCES INC |
|
|
$0 (exited) | COGT | 0 | -6,416,147 | $0 | EYEPOINT PHARMACEUTICALS INC |
|
|
$0 (exited) | EYPT | 0 | -3,370,506 | $0 | NEKTAR THERAPEUTICS |
|
|
$0 (exited) | NKTR | 0 | -18,700,000 | $0 | NANOSTRING TECHNOLOGIES INC |
|
|
$0 (exited) | NSTG | 0 | -1,723,373 | $0 | SOLENO THERAPEUTICS INC |
|
|
$0 (exited) | SLNO | 0 | -1,239,000 | $0 | TALARIS THERAPEUTICS INC |
|
|
$0 (exited) | TALS | 0 | -2,403,238 | $0 | VIRIDIAN THERAPEUTICS INC |
0 |
-2,007,946 |
$0 (exited) | VRDN | 0 | -2,007,946 | $0 |
See Summary: RA Capital Management L.P. Top Holdings
See Details: Top 10 Stocks Held By RA Capital Management L.P.
|
|